John Henderson

John Henderson

Net worth: 6 M $ as of 30/05/2026

81 year
Health Technology
Commercial Services
Finance

Profile

John Tannahill Henderson currently works at Cytokinetics, Inc., as Chairman from 2022.
Dr. Henderson also formerly worked at Asmacure Ltée, as Chairman, Myriad Genetics, Inc., as Independent Director in 2020, Inveresk Research Group, Inc., as Non-Executive Director, Myrexis, Inc., as Independent Director from 2011 to 2013, Pfizer Pharmaceuticals, Inc., as Vice President, Futurepharm LLC, as President, NeuroVia, Inc., as Chief Development Officer, and Pfizer Inc., as VP-Europe, US & International Pharmaceuticals.
Dr. Henderson received his undergraduate degree and doctorate degree from The University of Edinburgh.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
26/05/2026 78,171 ( 0.06% ) 6 M $ 30/05/2026

John Henderson active positions

CompaniesPositionStart
CYTOKINETICS, INCORPORATED Chairman 07/04/2022

Former positions of John Henderson

CompaniesPositionEnd
MYRIAD GENETICS, INC. Chairman 22/03/2020
Corporate Officer/Principal 30/09/2018
MYREXIS, INC. Director/Board Member 31/12/2012
Corporate Officer/Principal 30/11/2000
PFIZER INC. Corporate Officer/Principal 30/11/2000
See the detail of John Henderson's experience

Training of John Henderson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

48

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

Futurepharm LLC

Health Technology

  1. Stock Market
  2. Insiders
  3. John Henderson
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!